Risk Factors For Myelosuppression In Chronic Phase Cml Patients Treated With Imatinib Mesylate (Sti571).Michael J Mauro, Michael E Odwyer,Gwen Kurilik,Carolyn Blasdel,Melanie Farnsworth,Dyt Fong, Y C Hsieh,John M Ford,Brian J DrukerBLOOD(2001)引用 24|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要